Page last updated: 2024-10-22

amitriptyline and Atrophy

amitriptyline has been researched along with Atrophy in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MARIANI, E1
VELLA, G1

Other Studies

1 other study available for amitriptyline and Atrophy

ArticleYear
[CLINICAL CONSIDERATIONS ON A CASE OF MANIC-DEPRESSIVE PSYCHOSIS IN MIDDLE AGE, WITH CORTICAL ATROPHY AND INTELLECTUAL DETERIORATION].
    Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali, 1963, Dec-31, Volume: 87

    Topics: Amitriptyline; Atrophy; Bipolar Disorder; Brain Diseases; Cerebral Cortex; Humans; Imipramine; Memor

1963